Delivery Order SPE2DB22D3501-SPE2DB25FVD21
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,335.44, is for the delivery of 4,566,690,552 units of the pharmaceutical product MOXIFLOXACIN HCL 400 MG TABLET 30S. The contract has a firm-fixed price pricing structure and a performance period running through December 12, 2024. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,565,571,496 units of Moxifloxacin HCL 400 MG Tablet UD 50S, a pharmaceutical product, at a ceiling value of $2,691.00. The delivery order has a firm fixed price and an ultimate completion date of August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,752,422 units of the antibiotic moxifloxacin hydrochloride 400 mg tablets, with a completion date of May 31, 2024 and a ceiling value of $1,364.84. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026, enabling efficient...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $3,423.55 and an ultimate completion date of August 19, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a $1,146.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567553324 - MOXIFLOXACIN HCL 400 MG TABLET 30S, a generic pharmaceutical product, with a period of performance through March 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,424.06 firm fixed-price contract is for the supply of MOXIFLOXACIN 400MG 30S, a generic pharmaceutical product. The contract has an ultimate completion date of August 13, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,127.06 contract is for the delivery of 4,567,919,068 units of the antibiotic Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4563954862 - moxifloxacin hydrochloride 400 mg tablets. The contract has a ceiling value of $2,010.89 and a period of performance through March 14, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,507.02 firm fixed-price contract is for the delivery of MOXIFLOXACIN 400 MG/250 ML BAG 250ML, a type of medication, to support military healthcare programs. The IDC, valued at $999,999,999, serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award is for the delivery of 4,567,320,273 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablet. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 20, 2025. The contract is a Delivery Order with a Firm Fixed Price of $2,691.00 and a completion date of February 21, 2025. The contract does not have a set-aside designation. Amerisourcebergen holds a...